127(top 31%)
articles
2.6K(top 27%)
citations
25(top 27%)
★★ articles
3(top 14%)
★★★ articles
2.1(top 30%)
Avg IF
25(top 27%)
H-Index
49(top 25%)
G-Index
85
journals

Most Cited Articles of Johannes Wesling Klinikum Minden

TitleJournalYearCitations
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhageJAMA - Journal of the American Medical Association2015323
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined SourceNew England Journal of Medicine2019317
Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational studyAnnals of Neurology2010160
DNMT3A mutations in myeloproliferative neoplasmsLeukemia2011134
Diagnosis of nephrogenic systemic fibrosis by means of elemental bioimaging and speciation analysisAnalytical Chemistry201598
TGF-β: an emerging player in drug resistanceCell Cycle201391
Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devicesJournal of Heart and Lung Transplantation201485
Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function testsClinical Chemistry and Laboratory Medicine201483
European Recommendations on Organisation of Interventional Care in Acute Stroke (EROICAS)International Journal of Stroke201680
Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research PrioritiesStroke201677
Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trialStroke201464
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)Annals of Hematology201456
Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH RegistryVascular Medicine201052
Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) RegistryEuropean Journal of Vascular and Endovascular Surgery201052
Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testingLung Cancer201545
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient dataLancet, The202044
Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic strokeStroke201144
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE studyAnnals of Oncology201843
Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry EuropeHeart201139
Current and future treatment options for polycythemia veraAnnals of Hematology201535
Treatment of osteochondral fractures of the knee: a meta-analysis of available scientific evidenceInternational Orthopaedics201335
ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision makingLung Cancer201533
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpuraBlood Advances202033
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendationsLeukemia201733
A simple brain atrophy measure improves the prediction of malignant middle cerebral artery infarction by acute DWI lesion volumeJournal of Neurology201428